Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTD-2192J16.24 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
mRNA | LMTK2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | MID2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | RP11-298A10.1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | CD2BP2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | HOXD11 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | CLIC4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ARID3A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | RNASEK | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | VAMP8 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |